綠領控股(00061.HK)建議延長可換股票據到期日
格隆匯4月24日丨綠領控股(00061.HK)公吿,於2020年7月22日,公司與各認購人中國能源(香港)控股有限公司及郝婷女士訂立有條件認購協議,各認購人已有條件同意認購3.95億港元可換股票據。
可換股票據已根據可換股票據的現有條款及條件於2022年10月20日到期,且於本公吿日期全數仍未償還。
於2024年4月24日,公司、中國能源及郝女士訂立修訂契據,據此,公司、中國能源及郝女士有條件同意將可換股票據到期日由2022年10月20日延長至可換股票據經延長到期日(即完成日期的第二(2)個週年當日),而可換股票據的所有其他條款及條件均維持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.